Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Barrett Esophagus 2Gastroesophageal Reflux 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Endoscopes × Clear all
NCT04301986 2023-05-08

Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus

University of North Carolina, Chapel Hill

Phase NA Completed
24 enrolled 9 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT02729948 2019-01-23

Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus

University of Washington

Phase NA Completed
1 enrolled
Gastrointestinal

Barrett Esophagus

NCT01172860 2017-11-09

CCEE EndoVe

Mercy University Hospital, Cork, Ireland

Phase 1 Completed
10 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡